Blog

53 Articles

DNA image
Research
November 22, 2021 • 2 Min

Using Molecular Tumor Profiling to Determine the Best Pancreatic Cancer Treatment

A clinical trial looks at whether molecular subtyping of tumors is effective in determining the best pancreatic cancer treatment.

pancreatic cancer patient Rita Krueger, her husband and dog
Survivor Stories
November 1, 2021 • 4 Min

Choosing the Right Doctor

Rita Krueger made an important decision that changed her pancreatic cancer treatment when she got a second opinion.

Gehan Botrus
Research
July 26, 2021 • 5 Min

Finding More Clues about Circulating Tumor DNA

Researcher Dr. Gehan Botrus looks at circulating tumor DNA for genetic information on a patient’s pancreatic cancer to personalize treatment.

photo of the mineral bismuth
Survivor Stories
July 21, 2021 • 2 Min

The Importance of a Good Treatment Team

Wayne Mullis credits his treatment team with choosing the best pancreatic cancer treatment for him and for helping him through treatment.

Dr. Tanios Bekaii-Saab
Research
June 3, 2021 • 4 Min

Disappointing Results of a Phase II Trial Using Angiogenesis Inhibitor

Dr. Tanios Bekaii-Saab reports on the disappointing results of a trial combining an angiogenesis inhibitor and mFOLFIRINOX.

Dr. Allyson Ocean
Research
May 20, 2021 • 5 Min

Researching More Second-Line Options for Pancreatic Cancer

Dr. Allyson Ocean explains the concept behind a novel second-line treatment being tested for metastatic pancreatic cancer.

pancreatic cancer patient Michael Francis in a field of roses
Survivor Stories
February 17, 2021 • 3 Min

Time and Hope

Rose farmer Michael Francis wanted more time with his family, so he joined a clinical trial to treat his stage III pancreatic cancer.

white 3-d hexagons on a black background
Research
August 26, 2020 • 1 Min

Testing a New Approach to Treating Advanced Pancreatic Cancer

Scientists are testing a new drug that is an antagonist of stress hormone receptors, in combination with nab-paclitaxel, for advanced pancreatic cancer.

Image of a cancer drug target visualized at the atomic level
Research
July 7, 2020 • 2 Min

Slowing the Spread of Advanced Pancreatic Cancer

Researchers are testing a kinase inhibitor that is used to treat lung diseases, including a type of lung cancer, against pancreatic cancer.

Fractal flame ribbons in whte and red on a black background
Research
May 15, 2020 • 2 Min

Targeted Therapy to Inhibit Connective Tissue Growth in Pancreatic Cancer

Researchers are testing a new antibody, a type of targeted therapy, in combination with standard treatment for pancreatic cancer in a phase III trial.

Dr. E. Gabriela Chiorean
Treatments
December 27, 2019 • 5 Min

Chemotherapy: A Key Player in the Battle Against Pancreatic Cancer

Dr. Gabriela Chiorean walks us through the different types of chemotherapy treatments for pancreatic cancer and how they work. Join Let’s Win PC in our fight.

cancer targeted treatments in blue against a tan background
Research
August 6, 2019 • 2 Min

Comparing Two Types of Radiotherapy for Pancreatic Tumors that Cannot Be Surgically Removed

Researchers are comparing standard radiotherapy treatment with a newer type of radiation that uses heavy ions, for nonsurgical pancreatic cancer patients.

Purple question marks
Treatments
June 27, 2019 • 5 Min

Questions to Ask Before You Begin Chemotherapy

Do you want to better understand your pancreatic cancer treatment? Dr. Andrew Hendifar outlines important questions to ask before starting chemotherapy.

microscope image of the structure of blood vessel endothelium with the proteins that hold the shapes in red
Research
June 14, 2019 • 2 Min

Testing a New Drug to Attack Pancreatic Tumor Blood Vessels

A clinical trial is testing a new drug combination that damages the tumor blood vessels and allows chemotherapy drugs to enter the tumor.

black disc in motion against a yellow background
Research
December 12, 2018 • 2 Min

Electric Fields to Enhance Pancreatic Cancer Chemotherapy

A clinical trial uses electric fields to help slow the growth of tumor cells, In a clinical trial for pancreatic cancer patients.